首页 > 市场调查报告书 > 医疗设备

心血管设备

市场调查报告书

商品编码

1489237

全球植入式起搏器市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Implantable Pacemaker Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年05月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球植入式心律调节器市场需求预计将从 2023 年的 37.9 亿美元达到 2032 年近 55.3 亿美元的市场规模，2024-2054 年研究期间复合年增长率为 4.29%。

植入式心律调节器是一种调节心律不整或其他心臟病患者心跳的医疗设备。它透过手术植入皮下（通常靠近胸部），传递刺激心臟正常跳动的电脉衝。现代心律调节器是可编程的，可以根据患者的身体活动调整心律调节器。它们显着提高心律不整患者的生活品质和存活率，提供可靠且持续的心臟支持。

市场动态

植入式起搏器市场是由心血管疾病（特别是心律不整）日益流行所推动的，这需要使用心律调节器来调节心律并预防併发症。全球人口老化极大地促进了这一需求，因为老年人更容易患有需要植入心律调节器的心臟疾病。心律调节器设计和功能方面的技术进步，例如无引线起搏器和电池寿命更长的设备的开发，提高了患者的治疗效果和舒适度，从而促进了市场成长。此外，将远端监控功能整合到现代起搏器中可以对患者进行持续监控和及时的医疗干预，从而改善心血管疾病的管理并减少频繁去医院的需要。对心臟病的认识和诊断的提高，加上医疗基础设施的改善，尤其是在新兴经济体，也推动了植入式起搏器的采用。此外，支持性的政府政策和医疗保健报销计划使起搏器植入物更容易为更广泛的患者群体所接受。随着医疗保健提供者继续优先考虑先进的心臟护理以及起搏器技术创新的进步，对植入式起搏器的需求预计将保持强劲，推动市场进一步扩张。然而，严格的监管要求和高昂的开发成本可能会挑战未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球植入式心律调节器市场的各个细分市场进行了包容性评估。植入式起搏器产业的成长和趋势为本研究提供了整体方法。

市场区隔

植入式起搏器市场报告的这一部分提供了有关国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品分类

单室
双室
双心室

按申请

心律不整
心房震颤
心块
长QT症候群
充血性心臟衰竭
其他的

按最终用途

医院
门诊设施

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲植入式心律调节器市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。植入式心律调节器市场的主要参与者包括波士顿科学公司、佐尔医疗公司、美敦力公司、百多力公司、微创科学公司、库克、Medico SpA、Pacetronix、雅培、Osypka Medical GmbH。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：植入式心律调节器公司的竞争格局

植入式心律调节器市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
Boston Scientific Corporation

公司简介
公司收入
产品
最近的发展

Zoll Medical Corporation

公司简介
公司收入
产品
最近的发展

Medtronic

公司简介
公司收入
产品
最近的发展

Biotronik

公司简介
公司收入
产品
最近的发展

MicroPort Scientific Corporation

公司简介
公司收入
产品
最近的发展

Cook

公司简介
公司收入
产品
最近的发展

Medico SpA

公司简介
公司收入
产品
最近的发展

Pacetronix

公司简介
公司收入
产品
最近的发展

Abbott

公司简介
公司收入
产品
最近的发展

Osypka Medical GmbH

公司简介
公司收入
产品
最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR112114603

The global demand for Implantable Pacemaker Market is presumed to reach the market size of nearly USD 5.53 Billion by 2032 from USD 3.79 Billion in 2023 with a CAGR of 4.29% under the study period 2024-2054.

An implantable pacemaker is a medical device that regulates the heartbeat in individuals with arrhythmias or other heart conditions. Surgically implanted under the skin, commonly near the chest, it delivers electrical impulses that stimulate the heart to beat normally. Modern pacemakers are programmable and can adjust their pacing in response to the patient's physical activity. They significantly improve the quality of life and survival rates for individuals with heart rhythm disorders, providing reliable and continuous cardiac support.

MARKET DYNAMICS

The implantable pacemaker market is driven by the increasing prevalence of cardiovascular diseases, particularly arrhythmias, which necessitate using pacemakers to regulate heart rhythms and prevent complications. The aging global population significantly contributes to this demand, as older adults are more prone to heart conditions that require pacemaker implantation. Technological advancements in pacemaker design and functionality, such as the development of leadless pacemakers and devices with longer battery life, enhance patient outcomes and comfort, thereby boosting market growth. Additionally, integrating remote monitoring capabilities in modern pacemakers allows for continuous patient monitoring and timely medical intervention, improving the management of cardiovascular conditions and reducing the need for frequent hospital visits. Increased awareness and diagnosis of heart conditions, coupled with improved healthcare infrastructure, especially in emerging economies, are also driving the adoption of implantable pacemakers. Moreover, supportive government policies and healthcare reimbursement programs make pacemaker implants more accessible to a broader patient population. As healthcare providers continue to prioritize advanced cardiac care and as innovation in pacemaker technology progresses, the demand for implantable pacemakers is expected to remain strong, driving further market expansion. However, stringent regulatory requirements and high development costs may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Implantable Pacemaker. The growth and trends of Implantable Pacemaker industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Implantable Pacemaker market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Single Chamber
Dual Chamber
Biventricular Chamber

By Application

Arrhythmias
Atrial Fibrillation
Heart Block
Long QT Syndrome
Congestive Heart Failure
Others

By End Use

Hospitals
Outpatient Facilities

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Implantable Pacemaker market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Implantable Pacemaker market include Boston Scientific Corporation, Zoll Medical Corporation, Medtronic, Biotronik, MicroPort Scientific Corporation, Cook, Medico SpA, Pacetronix, Abbott, Osypka Medical GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. IMPLANTABLE PACEMAKER - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End Use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL IMPLANTABLE PACEMAKER MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data
5.3. Analysis By Product
5.4. Single Chamber Historic and Forecast Sales By Regions
5.5. Dual Chamber Historic and Forecast Sales By Regions
5.6. Biventricular Chamber Historic and Forecast Sales By Regions

6. GLOBAL IMPLANTABLE PACEMAKER MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data
6.3. Analysis By Application
6.4. Arrhythmias Historic and Forecast Sales By Regions
6.5. Atrial Fibrillation Historic and Forecast Sales By Regions
6.6. Heart Block Historic and Forecast Sales By Regions
6.7. Long QT Syndrome Historic and Forecast Sales By Regions
6.8. Congestive Heart Failure Historic and Forecast Sales By Regions
6.9. Others Historic and Forecast Sales By Regions

7. GLOBAL IMPLANTABLE PACEMAKER MARKET ANALYSIS BY END USE

7.1. Overview By End Use
7.2. Historical and Forecast Data
7.3. Analysis By End Use
7.4. Hospitals Historic and Forecast Sales By Regions
7.5. Outpatient Facilities Historic and Forecast Sales By Regions

8. GLOBAL IMPLANTABLE PACEMAKER MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE IMPLANTABLE PACEMAKER COMPANIES

9.1. Implantable Pacemaker Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF IMPLANTABLE PACEMAKER INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Boston Scientific Corporation
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Zoll Medical Corporation
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Medtronic
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Biotronik
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. MicroPort Scientific Corporation
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Cook
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Medico SpA
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Pacetronix
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Abbott
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Osypka Medical GmbH
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments